The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

NCT00511823 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea and Vomiting, Chemotherapy-Induced

Interventions

DRUG: casopitant
DRUG: dolasetron
DRUG: granisetron
DRUG: rosiglitazone

Sponsor

GlaxoSmithKline